Sysmex Europe SE is pleased to announce the official distribution launch of the geneLEAD® VIII platform manufactured by Precision Systems Science Co., Ltd. (“PSS” based in Matsudo, Chiba, Japan), a developer of instruments for in vitro diagnostics and SMD lead kits, now available to clinical laboratories through Sysmex Affiliates. The geneLEAD® VIII is a compact, fully automated system designed to streamline molecular diagnostics, integrating extraction and RT-qPCR into a single workflow. The system supports rapid turnaround with minimal hands-on time, offering results within 120 minutes.
The platform is complemented by the SMD lead kit range developed and produced by gerbion GmbH & Co. KG in Kornwestheim, Germany. The kits are designed for the qualitative detection of microbial and viral pathogens from various clinical specimen types, including respiratory, gastrointestinal, dermatological, and urogenital samples. The kits are intended for professional use in clinical and laboratory settings.
The lyophilized format of the SMD lead kits offers significant logistical advantages. Their shelf life of up to 12 months at room temperature eliminates the need for cold storage and simplifies transport—reducing handling complexity and easing day-to-day operations in the lab.
This launch marks the beginning of a collaboration between Sysmex Europe SE and SMD GmbH, aimed at expanding access to high-quality, molecular diagnostic solutions. The partnership leverages gerbion’s expertise in molecular assay development and production with Sysmex’s strong distribution network and local market knowledge to ensure responsive service and reliable product availability.
David Freiheit, CEO of SMD GmbH:
With Sysmex Europe SE, we are gaining a strong partner to jointly offer a forward-looking, fully integrated solution for PCR diagnostics – from instruments to kits. This partnership represents quality, innovation, and long-term collaboration. Together, we are opening up new perspectives in molecular diagnostics. We look forward to our journey ahead and to what we will accomplish together for our customers.
Carlos Martinez, Head of Life Science, Sysmex Europe SE:
We are pleased with the opportunity to partner with SMD, expanding Sysmex Life Science portfolio into the pathogen detection market. We are excited to incorporate the geneLEAD automated platform and SMD lead kits to our offer, to provide our customers with a PCR solution to move from sample to high-quality result in the nimblest way. This partnership strengthens our resolve to improve healthcare for patients affected by infectious diseases.
About SMD GmbH
SMD – Innovative Solutions for Molecular Diagnostics
SMD distributes cutting-edge solutions for molecular diagnostics, actively contributing to medical progress. The company unites a team of seasoned experts who have been working in the field for many years and channel their extensive expertise into the development of forward-looking technologies.
SMD is a German company based in Göppingen, providing its services and products to partners throughout the world. For more information, visit https://www.sm-dx.com/en
About Sysmex Europe SE
Sysmex supports healthcare professionals and patients around the world with a broad range of medical diagnostics products and solutions in a variety of fields. With over 50 years’ experience in in vitro diagnostics, we are continuously developing our product and service portfolio to cover the entire patient pathway of care. Our multi-functional solutions work together with high-quality reagents and reliable service and support to create a better healthcare journey for all.
Sysmex Europe SE, located near Hamburg, Germany, is a subsidiary of the Sysmex Corporation from Kobe, Japan. From our Hamburg offices, we serve our affiliates, distributors and customers throughout Europe, the Middle East, and Africa (EMEA). For more information, visit www.sysmex-europe.com.
